For the first time… the FDA approves an effective topical treatment for vitiligo

[ad_1] The US Food and Drug Administration (FDA) has approved Opzelura, also known as Ruxolitinib 1.5%, as an effective topical treatment for chronic vitiligo, according to a statement by Incyte, the drug’s manufacturer. Vitiligo is a chronic disease, which leads to the loss of pigment in some areas on the […]